Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 8 | 6 | 0 | 1 |
| TOTAL | $0 | $10 | $10 | $0 | $1 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $10 | $10 | $0 | $1 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 20 | 20 | 20 | 20 |
| Accounts payable and accrued liabilities | 978 | 917 | 820 | 581 | 499 |
| Accrued Expenses | 224 | 224 | 226 | 226 | 234 |
| TOTAL | $1,291 | $1,248 | $1,205 | $967 | $1,084 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,291 | $1,248 | $1,205 | $967 | $1,084 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 787,688 | 770,361 | 770,361 | 693,997 | 642,913 |
| Common Shares | 780 | 770 | 722 | 684 | 606 |
| Retained earnings | -18,821 | -18,671 | -18,505 | -18,197 | -18,038 |
| Other shareholders' equity | 25 | 10 | 5 | 0 | 0 |
| TOTAL | $-1,291 | $-1,238 | $-1,195 | $-966 | $-1,083 |
| Total Liabilities And Equity | $0 | $10 | $10 | $0 | $1 |